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Retroviral RNA-dependent DNA polymerase (reverse transcriptase or RT) uses the 3’OH end of a cellular tRNA as primer to initiate DNA synthe- 
sis. Previous work with avian retrovirus has shown that reverse transcriptase is implicated in the selection of cellular virion-encapsidated tRNAs 
and has shown that the primer tRNA is positioned on the primer binding site near the 5’ end of the viral RNA. These mechanisms upport the 
idea that the retroviral polymerase should form complexes with primer tRNA and the specific encapsidated ones. The genomic sequence of human 
immunodeficiency virus (HIV) allows the prediction that tRNA LysJ is the natural primer. In this article we show, using the mobility shift assay, 
that recombinant HIV reverse transcriptase is able to form a complex with bovine tRNALy*. By fluorescence studies and a-chymotrypsin analysis 
we have observed a modification of the enzyme conformation when reverse transcriptase is bound to the putative primer tRNA. This structural 
change is specific for tRNALp although the retroviral polymerase is able to interact with other tRNAs. 
HIV; Reverse transcriptase; Primer tRNA recognition 
1. INTRODUCTION 
Human immunodeficiency virus is the causative 
agent of AIDS [ 1,2]. As is the case for all retroviruses, 
HIV genomic single stranded RNA is reverse transcrib- 
ed into double stranded DNA by a virus encoded and 
virion-encapsidated RNA-dependent DNA polymerase 
[3]. Retroviral RT initiates DNA synthesis in vivo from 
the 3 ‘OH end of a host tRNA which is partially anneal- 
ed to a complementary region near the 5’ end of the 
viral genome (primer binding site or PBS) [4]. Previous 
work of our laboratory has dealt with the specific 
recognition of bovine primer tRNATm by avian 
myeloblastosis virus (AMV) RT. The avian hetero- 
dimeric enzyme seems to be involved in the binding, in 
the partial unwinding and positioning of host tRNATp 
on the retroviral PBS [5,6]. More recently it was shown 
that a retrovirus-encoded small basic nucleocapsid pro- 
tein is also involved in primer-template annealing [7]. 
Little is known about the interactions of RT and 
primer tRNA other than those in avian retroviruses. 
Recently, we have been involved in the study of the 
mechanism of action of recombinant HIV RT produced 
in transformed yeast [&X,9]. The human retroviral DNA 
polymerase, as in the case of the avian RT, is an 
heterodimer. HIV RT is formed by a p66 subunit and a 
~51 subunit derived by proteolytic cleavage near the 
carboxyl-end of the p66 peptide [lo]. This partial 
maturation is probably performed by the HIV encoded 
acid protease. HIV genomic nucleotide sequence deter- 
mination [ll] allowed the prediction that the host 
tRNA that serves as the primer for HIV RT is human 
tRNALYS3 [121. Animal cells contain several isoacceptor 
forms of tRNALyS. This tRNA is highly conserved as 
evidenced by sequence studies of tRNALyS and tDNALyS 
genes from rat, rabbit and human cells [13]. Our recent 
results demonstrate that HIV RT is able to form a com- 
plex with a highly purified bovine tRNALYS fraction 
containing the three tRNALyS isoacceptors [9]. We used 
both a direct approach by centrifugation in glycerol 
gradients and an indirect one, by the specific protection 
of enzyme activity by bovine tRNALYS against thermal 
denaturation and trypsin digestion. Moreover, tRNALyS 
is able to affect HIV RT DNA polymerase activity, the 
effect being different when the heterodimer (p66/p51) 
or the homodimer (~661~66) enzyme forms are in- 
cubated with primer tRNA [14] 
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In this article we show, by gel retardation, that 
recombinant HIV RT expressed in yeast is able to form 
a complex with bovine tRNALyS with a higher affinity 
than with tRNATTp, while other tRNAs are not 
recognized by the enzyme. By following the 
fluorescence emission of the enzyme in the presence of 
different tRNAs, as well as by the study of the ac- 
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cessibility of the HIV RT-tRNALYS complex to LY- 
chymotrypsin, we show that the formation of the en- 
zyme-primer tRNA complex can lead to dramatic pro- 
tein structural changes. 
Unlabeled tRNA LYS 
Concentration (FM) 1 2 5 10 
Radioactive tRNA LYS 
__~_. 
Top of the gel j _ 
2. MATERIALS AND METHODS Retarded tRNA j 
2.1. Materials 
Unlabeled nucleotides, oligonucleot~des and polynucleotides were 
obtained from Sigma Chem. Co or Pharmacia. Radio-isotopes were 
from the C.E.A.-Saclay (France) and Amersham. Beef tRNAs were 
purified as previously described [15]. Recombinant HIV RT expressed 
in yeast cells was purified as described before [9]. 
2.2. Gel retardation experiments 
Binding reactions for bandshift assays contained, in 15 ~1, 50 mM 
Tris-HCI, pH 8.0, 100 mM KC1, 15 mM MgCls, 6% glycerol (v/v), 0.5 
mM 2-mercaptoethanol and tRNAs labeled at the 5’ end with 
[Y-~~P]ATP. Binding reactions were initiated by adding the RT and 
complexes were allowed to form for 10 min at 4°C. Then, the mix- 
tures were loaded onto a 6% non-denaturing polyacrylamide gel con- 
taining TBE 1X (89 mM Tris-HCl, pH 8.3, 89 mM boric acid, 1 mM 
EDTA), prerun for 30 min at 12 V/cm and electrophoresed until a 
suitable separation was achieved at the same voltage. Migration was 
followed by adding Bromophenol blue to a sample containing only 
radioactive tRNA used as a control. After electrophoresis the gel was 
fixed with 5% methanol, 5% acetic acid for 30 mitt, dried and 
autoradiographed. 
Free tRNA j 
Lanes 1234 
Fig. 1. Detection of tRNAs binding by HIV RT visualized by gel retar- 
dation electrophoresis. Each lane contains 2.5 pM recombinant HIV 
RT, the indicated concentrations of unlabeled tRNAs and 10 000 cpm 
of (32P]tRNA’.yS (lanes I-4, 9-10) or 10 000 cpm of [“F]tRNATm 
2.3. Fluorescence emission sperira of HIV RT (lanes 5-8). Lanes 9-10 also contains 2 pM tRNALY”. 
HIV RT and tRNAs were incubated in 50 mM phosphate buffer, 
pH 6.0, 100 mM KCl, 10 mM MgCh, 1 mM DTT, 1% glycerol for 10 
min before the spectra were recorded at 25°C on a thermostated 
SPF-500 Aminco spectrofluorimeter. Excitations were performed at 
295 nm. The fluorescence from the buffer was substracted from the 
fluorescence data of the enzyme. 
2.4. Digestion of HIV reverse tra~scr~~~~e by ff-c~ymo~ry~~~ 
Recombinant HIV RT (0.03 pM) was preincubated in a buffer con- 
taining 50 mM Tris-HCI, pH 7.5,0.5 mM 2-mercaptoethanoi, 0.01% 
Triton-X100,5% glycerol in the presence or absence of 0.4 gM tRNA 
for 10 min, then o-chymotrypsin was added for 30 min at 25°C. The 
proteolytic reaction was stopped by addition of 6 mM 
phenyImefhytsuIfony1 fluoride and the remaining activity of the RT 
tested as described before using poly rA-dTir as template-primer 191. 
2.5. Immunablatting of HIV RT 
Digestion of HIV RT (1.2 FM) by increasing amounts of LY- 
chymotrypsin for 10 min at 0°C was performed as described in the 
previous paragraph. Production of rabbit anti-HIV RT antibodies 
and immunoblotting were performed as already described fl4]. 
a complex between HIV RT and tRNATrp by using the 
same technique (lanes 5-8). Unlabeled tRNAVa’ did not 
compete with tRNALyS (lane 9) while 5 PM of unlabeled 
tRNATrr’ can partly displace tRNALyS (lane 10). In com- 
petition experiments, we have observed that the HIV 
RT/tRNATrP complex is displaced by lower concentra- 
tions of tRNALy” than the HIV RT/tRNALYS complex 
by tRNATrp (results not shown). This may indicate that 
HIV RT has a better affinity for its putative primer 
tRNALyS. The migration position of the retarded 
tRNALyS or tRNATrp is the same suggesting an equi- 
valent stoichiometry of the complex between HIV RT 
and these two tRNAs. 
3. RESULTS AND DISCUSSION 
The specific complex formed between nucleic acids 
and proteins can be studied by different techniques. 
The approach of gel retardation has been extremely 
useful to study this kind of interactions f16]. Using this 
technique, we have shown the formation of a complex 
between a highly purified fraction of tRNALy” (contain- 
ing the 3 isoacceptors) and HIV RT. In Fig. 1 it can be 
seen that HIV RT can retard labeled tRNALy” and that 
the addition of various amounts (up to 10 PM) of 
unlabeled tRNALyS was able to displace the retarded 
radioactive tRNALyS (lanes l-4). We have also observed 
HIV RT is extremely rich in aromatic residues. Thus, 
analysis of thepof domain sequence shows the presence 
of 19 t~ptophan residues [l l]. This property ahowed 
us to study by spectrofluorometry the interactions bet- 
ween the enzyme and its primer tRNA. When RT was 
excited at 295 nm (mainly affecting the tryptophan 
residues), it showed an emission spectrum with a max- 
imum at 338 nm (Fig. 2). The addition of tRNALyS to 
RT induced an important shift of this m~imum to 
about 355 nm. The new emission spectrum induced 
specifically by tRNALyS is characteristic of the exposure 
to the solvent of tryptophan residues previously buried 
in the enzyme [ 171, suggesting that the complex between 
the retroviral DNA polymerase and its specific primer 
leads to important protein structural changes. Other 
tRNAs (Trp or Val) were not able to induce such a shift; 
240 
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Fig. 2. Fluorescence mission spectra of HIV RT. HIV RT and tRNAs 
were incubated as described in section 2. Excitations were performed 
at 295 nm on 0.5 pM RT alone (-); 0.5 CM RT plus 0.5 PM 
tRYAL”‘ (-----); 0.5 pM RT plus 0.5 /IM tRNATlp (....). 
in the presence of tRNATrp we only observed a 
noticeable fluorescence quenching at 338 nm. 
In order to verify that the binding of tRNALyS could 
affect the enzyme structure, we studied the protease ac- 
cessibility of HIV RT in the presence or absence of 
tRNA. We chose chymotrypsin, a protease hydrolyzing 
peptide bonds on the carboxyl side of aromatic amino 
acids. Moreover, it has been described that, under mild 
incubation conditions, cY-chymotrypsin digests the p66 
subunit to give a p66-~51 dimer very similar to the 
virion encapsidated polymerase [181. Using those condi- 
tions, we found (Fig. 3a) that RT was relatively resistant 
to cY-chymotrypsin (50% of enzyme activity was lost at 
4 PM protease); but when RT was preincubated with 
tRNALyc, it became strongly sensitive to CY- 
chymotrypsin digestion since a 50% inactivation was 
observed at 0.2 PM protease. No effect of tRNaVal on 
the activity of HIV RT in the presence of protease was 
observed. These results indicate that the accessibility of 
RT to the protease is greatly increased in the presence of 
the specific primer tRNA, thus confirming the fluores- 
cent data that indicated important structural changes in 
the enzyme structure induced by tRNALyS. 
The digestion of RT by cY-chymotrypsin was also 
followed by immunoblotting after SDS-PAGE using an 
anti-HIV RT polyclonal antibody. Fig. 3b shows the 
protein bands obtained after incubation with different 
concentrations of a-chymotrypsin. Discrete degrada- 
tion bands were observed. The results obtained when 
the enzyme was incubated in the presence or in the 
absence of tRNALyS (Fig. 3c) showed that with the 
putative tRNA primer, fainter bands were observed. As 
equal amounts of protein were added to each lane, there 
are probably smaller peptides running out of the gel 
that can not be visualised. It is interesting to note that 
the enrichment in the ~51 band, at low protease concen- 
tration does not lead to an important decrease in en- 
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Fig. 3. Partial cY-chymotypsin digestion of HIV RT. Panel a: cy- 
chymotrypsin digestion of HIV RT (0.03 PM) in the absence of tRNA 
(a--O), in the presence of 0.4 pM of tRNALyS (o---O), or 0.4 pM 
of tRNAVa’ (W-O). Results are expressed as the percentage of the 
remaining activity of the RT using polyrA-dT1z as template-primer. 
Panel b: immunoblotting of HIV RT (1.2 PM) after digestion in the 
presence of increasing amounts of ol-chymotrypsin. Panel c: com- 
parison of the product of digestion of HIV RT (1.2 PM) by a- 
chymotrypsin (17 PM) visualized by immunoblotting. Lane 1, non- 
digested RT; lane 2, a 15 min digested RT without rTNA; lane 3, a 15 
min digested RT after being preincubated in the presence of 20 pM 
tRNALY‘. mw: molecular weight (94, 67, 43, 30, 20 kDa). 
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zyme activity. This is in agreement with the results 
described using the activity gel technique [191, as well as 
those observed when active recombinant HIV RT was 
expressed after extensive deletions at the 3 ’ end of the 
coding region of the RT gene [20], indicating that both 
the p5 1 and the p66 subunits carry the DNA polymerase 
activity. 
It seems that three families of tRNA can be 
distinguished regarding their ability to form a complex 
with HIV RT: a first class with a high affinity, like 
tRNaLYS the natural primer, which is the best recogniz- 
ed and which induces an important change in confor- 
mation of the enzyme; a second class, including 
tRNATrp and probably other tRNAs, which form a 
lower affinity complex with the enzyme inducing minor 
changes in HIV RT structure, and a third family of 
tRNA which is too poorly recognized by the enzyme to 
allow complex detection by the usual methods. The 
lower affinity of the HIV RT/tRNATrP complex may 
explain that using glycerol gradient or nitrocellulose 
binding we did not detect this complex [9], Association 
is also observed by gel retardation between HIV RT and 
each tRNALyS isoacceptor purified by two-dimensional 
electrophoresis (D.R., unpublished results). Given the 
structural similarities between the 3 bovine isoacceptors 
these results are not surprising. It remains to be 
established if the affinity between the retroviral enzyme 
and each tRNALy” isoacceptor is quantitatively dif- 
ferent. It is interesting to point out that crosslinking 
studies showed very recently that the anticodon region 
of tRNALyS seems to be in close interaction with HIV 
RT 1211. Whether this observation is related to the ef- 
fect we have shown of the anticodon region of tRNALyS 
on the DNA polymerase activity of the homodimeric 
and heterodimeric forms of HIV RT, remains to be 
established [141. 
In conclusion, two different experimentai approaches 
described in this work (fluorescence shift and ac- 
cessibility of the enzyme to ar-chymotrypsin digestion) 
indicate that the interactions between HIV RT and 
animal tRNALyS can lead to important protein struc- 
tural changes. Work performed on the mechanism of 
retrovirus replication may be extremely relevant to ar- 
rest retroviral proliferation. A significant part of these 
studies have been devoted to the interactions between 
RT and primer tRNA. Work is in progress to map the 
enzyme region(s) involved in tRNALyS binding, as well 
as on the tRNA regions recognized by the retroviral 
polymerase. 
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